Discordant Response or Progression in Patients with Myeloma Treated with Thalidomide-based Regimens

Αchilles Anagnostopoulos; George Hamilos; M.P. Zorzou; Vasiliki Grigoraki; Dimitra Anagnostou; Meletios A Dimopoulos

doi:10.1080/1042819031000151860

Abstract

1 min read

Our data indicate that after treatment with TBR some patients with myeloma show discordant responses of the monoclonal protein levels and the bone marrow or extramedullary plasmacytosis. If our data are confirmed, they may have practical implications for assessment of response and follow up of patients treated with TBR.

Related publications

Article2017

Successful treatment with lenalidomide dexamethasone for second relapse of a patient with non-secretory multiple myeloma with extramedullary liver plasmacytomas: A case report

González Soares Sara María, Terpos Evangelos, Roussou Maria, Magdalini Migkou, Ioannis Ntanasis‐Stathopoulos, Efstathios Kastritis, Meletios A Dimopoulos

Article2014

Elevated Involved Light Chains Discordant to the Increase of the Involved Heavy Chains Identifies a Subset of Multiple Myeloma Patients with Worse Outcome

Erel Joffe, Yaël C. Cohen, Irit Avivi, Noam Benyamini, Svetlana Trestman, Viki Held, Meletios A Dimopoulos, Efstathios Kastritis

Article2007

Thalidomide Based Regimens (TBR) for Relapsed/Refractory Multiple Myeloma Patients: Long Term Follow Up, Unmaintained Remissions and Disease Control after Subsequent Treatments.

Μαρία Ρούσσου, Efstathios Kastritis, Αchilles Anagnostopoulos, Evangelos Eleftherakis-Papaiakovou, Charis Matsouka, Despina Barmparousi, Magdalini Migkou, Meletios A Dimopoulos

Article2004

Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors

Αchilles Anagnostopoulos, Dimitra Gika, George Hamilos, Konstantinos Zervas, Athanasios Zomas, Anastasia Pouli, M.P. Zorzou, Efstathios Kastritis, Nikolaos Anagnostopoulos, Anna Tassidou, Dimitra Anagnostou, Meletios A Dimopoulos

Article2004

Prognostic Factors and Outcome of Older Patients with Symptomatic Multiple Myeloma: A Study of the Greek Myeloma Study Group (GMSG).

Αchilles Anagnostopoulos, Dimitra Gika, Argiris Symeonidis, Konstantinos Zervas, Anastasia Pouli, Panagiotis Repoussis, Vassiliki Grigoraki, Nikolaos Anagnostopoulos, Alice Maniatis, Meletios A Dimopoulos